Prot# FavId-06: Phase III, Randomized, Double Blind Placebo-Controlled Trial of FavId and GM-CSF versus Placebo and GM-CSF Following Rituximab in Subjects with Follicular B-Cell Non-Hodgkin's Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date10/13/044/13/06

Funding

  • Favrille, Inc. (FavId-06)